UNSPSC 51287011: Etocarlide

This classification denotes an antitubercular agent with the molecular formula C17H20N2O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 46V3V5EQAM, chemically known as 4,4-diethoxythiocarbanilide but more generally known as etocarlide, which bears US NIH Compound Identifier 667483. European Medicines Agency schedules Etocarlide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07314MIG.

The term ETOCARLIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 26, No. 10 1972, List 12). ETOCARLIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: S=C(NC1CCC(OCC)CC1)NC1CCC(OCC)CC1.

UNSPSC 51287011 Etocarlide is a Commodity code that, based on recent state and local opportunities, covers pharmaceutical products and medical supplies procured through cooperative purchasing agreements and competitive bidding. The recent solicitations show state and local health agencies acquiring naloxone, drug deactivation systems, and other pharmaceutical inventory to support public health and community health initiatives. State and local issuing bodies under this code include state health departments and county health authorities. Illinois Department of Public Health and Seminole County, Florida represent the recent buyer base, with procurement occurring through both piggyback cooperative purchasing vehicles and traditional competitive bidding processes. The work involves identifying qualified pharmaceutical suppliers, negotiating pricing for bulk orders, ensuring compliance with drug-handling and storage requirements, and managing recurring supply contracts with multiple renewal periods.

Recent activity spans Illinois and Florida. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract to Chartwell Rx LLC through the MMCAP Infuse consortium on August 28, 2026 via an Invitation for Bid process for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets under solicitation 26482DPHPREPDB53392, with an initial 12-month term and two renewal options. Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response deadline, requiring quarterly deliveries to the Seminole County Community Health Building in Sanford, with an initial two-year contract term and one-year renewal option. Both procurements emphasize vendor compliance with federal and state requirements, including E-Verify, drug-free workplace certification, and insurance coverage.